TickerFactsScreenerDevelopers

Marker Therapeutics, Inc. (MRKR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$925.0K2012: -$1.59M2013: -$694.6K2014: -$2.19M2015: -$4.34M2016: -$6.51M2017: -$8.44M2018: -$14.48M2019: -$18.28M2020: -$20.03M2021: -$27.28M2022: -$26.97M2023: -$16.44M2024: -$10.91M2025: -$12.01M-$12.01M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$12.01M-10.1%
2024-$10.91M+33.6%
2023-$16.44M+39.0%
2022-$26.97M+1.1%
2021-$27.28M-36.2%
2020-$20.03M-9.6%
2019-$18.28M-26.3%
2018-$14.48M-71.6%
2017-$8.44M-29.6%
2016-$6.51M-49.9%
2015-$4.34M-98.6%
2014-$2.19M-214.9%
2013-$694.6K+56.3%
2012-$1.59M—
2010-$925.0K—